Core Scientific (NASDAQ:CORZ) Earns Buy Rating from BTIG Research

Core Scientific (NASDAQ:CORZ)‘s stock had its “buy” rating restated by research analysts at BTIG Research in a research note issued to investors on Thursday, Benzinga reports. They currently have a $38.00 price objective on the stock. BTIG Research’s price objective indicates a potential upside of 192.31% from the stock’s previous close.

Other equities analysts have also issued research reports about the stock. B. Riley Financial increased their price target on shares of Core Scientific from $33.00 to $42.00 and gave the company a “buy” rating in a research report on Monday, August 3rd. Canaccord Genuity Group increased their price target on shares of Core Scientific from $30.00 to $36.00 and gave the company a “buy” rating in a research report on Wednesday, July 29th. Wolfe Research restated a “buy” rating on shares of Core Scientific in a research report on Wednesday, July 29th. Cantor Fitzgerald restated an “overweight” rating and set a $39.00 price target on shares of Core Scientific in a research report on Wednesday. Finally, Capital One Financial set a $33.00 price target on shares of Core Scientific in a research report on Thursday, July 30th. Two investment analysts have rated the stock with a Strong Buy rating, eighteen have issued a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $31.36.

Core Scientific Stock Down 3.8%

CORZ stock traded down $0.51 during midday trading on Thursday, reaching $13.00. 15,752,160 shares of the company’s stock traded hands, compared to its average volume of 12,599,566. The company has a market cap of $4.18 billion, a price-to-earnings ratio of -2.94 and a beta of 5.49. The firm’s fifty day moving average price is $17.58 and its 200-day moving average price is $21.05. Core Scientific has a 52 week low of $12.31 and a 52 week high of $30.46.

Core Scientific (NASDAQ:CORZ) last announced its quarterly earnings results on Tuesday, July 28th. The company reported ($3.32) EPS for the quarter, missing analysts’ consensus estimates of ($0.06) by ($3.26). The business had revenue of $164.20 million for the quarter, compared to analyst estimates of $144.83 million. Analysts forecast that Core Scientific will post -1.36 earnings per share for the current year.

Insiders Place Their Bets

In other Core Scientific news, insider Todd DuChene sold 10,000 shares of the stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $19.97, for a total transaction of $199,700.00. Following the completion of the transaction, the insider owned 1,969,101 shares in the company, valued at $39,322,946.97. This trade represents a 0.51% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In the last three months, insiders have bought 19,000 shares of company stock worth $342,290 and have sold 100,000 shares worth $1,881,300. 1.70% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Core Scientific

A number of institutional investors and hedge funds have recently modified their holdings of CORZ. BlackRock Inc. purchased a new stake in shares of Core Scientific in the second quarter worth about $719,649,000. Apollo Management Holdings L.P. purchased a new stake in shares of Core Scientific in the second quarter worth about $115,671,000. Fifth Third Bancorp purchased a new stake in shares of Core Scientific in the first quarter worth about $59,802,000. Avala Global LP purchased a new stake in shares of Core Scientific in the second quarter worth about $101,729,000. Finally, Bank of America Corp DE lifted its holdings in shares of Core Scientific by 412.5% in the first quarter. Bank of America Corp DE now owns 4,806,363 shares of the company’s stock worth $71,903,000 after buying an additional 3,868,535 shares in the last quarter.

Trending Headlines about Core Scientific

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: Analysts continue to see substantial upside. Canaccord Genuity reaffirmed a “buy” rating with a $36 price target, while BTIG Research maintained its “buy” rating and set a $38 target. Cantor Fitzgerald also reiterated an “overweight” rating with a $39 target. These targets imply significant appreciation from recent trading levels and may support investor confidence. Canaccord Genuity Core Scientific rating
• Positive Sentiment: Core Scientific’s data-center and AI infrastructure strategy remains a key catalyst. The company’s high-density colocation business could benefit from demand for AI and high-performance computing capacity, helping explain why analysts maintain bullish targets despite recent volatility.
• Neutral Sentiment: Third-quarter results are scheduled for November 5, 2026. Management will release results before the market opens and host a conference call at 8:30 a.m. Eastern Time. Investors will likely focus on colocation growth, customer concentration, capital spending, and the outlook for AI infrastructure. Core Scientific earnings announcement
• Negative Sentiment: Insider selling adds a modest negative signal. Director Todd DuChene sold 10,000 shares for approximately $151,200, reducing his holdings by 0.85%. Although he still owns more than 1.15 million shares, the transaction may weigh on sentiment. Core Scientific insider sale
• Negative Sentiment: Tenant-related credit risk remains an overhang. Needham maintained its $35 target even as CoreWeave, a key tenant, faces credit pressure. Any deterioration in CoreWeave’s financial condition could raise concerns about customer concentration, contract execution, or payment risk. Needham Core Scientific target

Core Scientific Company Profile

Core Scientific, Inc is a digital infrastructure company that develops and operates data centers in the United States. Its business has historically centered on cryptocurrency mining, particularly the processing of transactions on the Bitcoin network, while also providing hosting and infrastructure services to other mining and technology customers.

The company is expanding its data center capabilities to support high-performance computing and artificial intelligence workloads. Its services include data center operations, power and equipment management, hosting, and related infrastructure support for customers that require substantial computing capacity.

Core Scientific was founded in 2017 and became a publicly traded company through a business combination in 2022.